A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2004
12/29/2004	EP1123509B1 Methods of diagnosing or prognosing alzheimer's disease
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1066037B1 Use of indole-2,3-dione-3-oxime derivatives as ampa antagonists
12/29/2004	EP0941092B1 Use of nk-1 receptor antagonists for treating major depressive disorders
12/29/2004	EP0915701B1 Fast-dissolving galanthamine hydrobromide tablet
12/29/2004	EP0869958B1 Novel indole-2,3-dione-3-oxime derivatives
12/29/2004	EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004	EP0653940B1 Glial mitogenic factors, their preparation and use
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558946A New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/29/2004	CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/29/2004	CN1558904A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
12/29/2004	CN1558894A Method for the nitration of phenolic compounds
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CN1558770A Method of preventing cell death using segments of neural thread proteins
12/29/2004	CN1558767A A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558764A Substituted urea neuropeptide Y Y5 receptor antagonists
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1558756A Pharmaceutical compositions for the treatment of urinary disorders
12/29/2004	CN1557811A Phenoxy indenone compounds ,process for preparing same and use thereof
12/29/2004	CN1557488A Preparation for treating intractable chronic pain and its preparing process
12/29/2004	CN1557476A Multiple biological activity polypeptide nutrient
12/29/2004	CN1557457A Smoking stopping products and its preparing process
12/29/2004	CN1557453A Memory and perception improving pure natural composite preparation and its preparing process
12/29/2004	CN1557448A Gynostemma pentaphylla capsule
12/29/2004	CN1557444A Preparing process of sobering up and clearing away heat healthy product series
12/29/2004	CN1557414A Orally disintegrating tablet of corydalis rhizome and its preparation
12/29/2004	CN1557413A Sustained and controlled release preparation of corydalis rhizome and its preparation process
12/29/2004	CN1557388A Poisonous element content decreasing Kawa extracts and its composition and preparing method
12/29/2004	CN1557385A Chinese medicine for treating catatonic type headache
12/29/2004	CN1557384A Chinese medicine contained honey for treating insomnia and hypertension and its application
12/29/2004	CN1557383A Bi-ant contained dampness dispelling and collaterals dredging medicinal capsule
12/29/2004	CN1557382A Glucoside compound preparation and its preparing process
12/29/2004	CN1557377A Cigarette toxin resisting heath product preparation and its preparing process
12/29/2004	CN1557353A Preparing and quality controlling method of Chinese traditional medicine composition
12/29/2004	CN1557346A Whole gastrodia tuber dripping pills and its preparing process
12/29/2004	CN1557343A Yin-nourishing and heat-clearing, mental anxiety easing preparation
12/29/2004	CN1557331A Oral prescription of cytidine triphosphate
12/29/2004	CN1557325A Pain killing medicine compostion
12/29/2004	CN1557320A Meloxicam containing skin topical paste formulation
12/29/2004	CN1557294A Oryzanol containing soft capsule preparation method
12/29/2004	CN1182136C Novel pyrrolo-(3,4-B) quinoline derivatives, method for prodn. and use thereof as medicament
12/29/2004	CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
12/29/2004	CN1182129C Benzopyran derivatives having leukotriene-antagonistic action
12/29/2004	CN1182127C Substituted 2-benzo [c] furanone compound, its preparing process and pharmaceutical composition containing same
12/29/2004	CN1181890C Use of enterobacterium protein OmpA in the preparation of antigen presentation cells specified targeting medicine
12/29/2004	CN1181885C Administration of polypeptide growth factors after central nervous system ischemia or trauma
12/29/2004	CN1181882C Ointment of Chinese herbal medicine for reactivating nerve and its manufacturing method
12/29/2004	CN1181855C Preparing method of hypericum perforatum extract
12/29/2004	CN1181840C Medicine for treating Alzheimer disease and cerebral ischemia encephalopathy and its preparation
12/29/2004	CN1181826C Lipid-based immune regulator composition
12/29/2004	CN1181822C Use of 2-amino-3,4-dihydro-quinazolines for producing medicament for treating or preventing diseases caused by ischaemia conditions
12/29/2004	CA2692334A1 Gaboxadol for treating depression and other affective disorders
12/29/2004	CA2530461A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
12/29/2004	CA2530023A1 Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/29/2004	CA2529805A1 Gaboxadol for treating depression and other affective disorders
12/29/2004	CA2529633A1 Methods for the diagnosis and prognosis of alzheimer's disease
12/29/2004	CA2529298A1 Indole derivatives as serotonin reuptake inhibitors
12/29/2004	CA2529268A1 Pharmaceutical formulations of amyloid inhibiting compounds
12/29/2004	CA2529254A1 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
12/29/2004	CA2528711A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof
12/29/2004	CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004	US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
12/28/2004	US6835740 Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride
12/28/2004	US6835738 Phenylalanine enamide derivatives
12/28/2004	US6835733 Tropane linked benzofuran derivatives
12/28/2004	US6835732 Modulation of the adenosine A2A receptor; cardioprotective agents; antiischemic agents; antihypoxia agents; central nervous system disorders, Alzheimer's disease, Parkinson's disease, anxiolytic agents; antidepressants; analgesics
12/28/2004	US6835730 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof
12/28/2004	US6835728 Drug combination for the treatment of depression and related disorders comprising mirtazapine
12/28/2004	US6835715 Mammalian dihydroouabain-like factor and therapeutic compositions
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835709 Uses an anisaldehyde as the stimulative agent.
12/28/2004	US6835567 PNS cell lines and methods of use therefor
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	US6835194 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
12/28/2004	CA2281426C Substituted indole compounds as anti-inflammatory and analgesic agents
12/28/2004	CA2240329C Improved delivery of multiple doses of medications
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/28/2004	CA2126072C Tri-substituted phenyl derivatives and processes for their preparation
12/28/2004	CA2072874C Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides
12/27/2004	CA2451268A1 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
12/23/2004	WO2004111250A1 Recombinant adeno-associated virus vector for treatment of alzheimer disease
12/23/2004	WO2004111226A1 Urokinase plasminogen activator derived octapeptide in the treatment of multiple sclerosis
12/23/2004	WO2004111061A1 ACYLATED AND NON-ACYLATED IMIDAZO[2,1-b]-1,3,4,-THIADIAZOLE-2-SULFONAMIDES, AND USES THEREOF
12/23/2004	WO2004111060A1 IMIDAZO[2,1-b]-1,3,4-THIADIAZOLE SULFOXIDES AND SULFONES
12/23/2004	WO2004111052A1 Pyrrolopyrimidine derivatives as modulators of multi-drug resistance (mdr)
12/23/2004	WO2004111040A1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists
12/23/2004	WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
12/23/2004	WO2004111022A1 3-(1,1-DIOXOTETRAHYDRO-1,2-THIAZIN-2-YL) or 3-(1,1-DOXO-ISOTHIAZOLIDIN-2YL) SUBSTITUTED BENZAMIDE COMPOUNDS AS ASP2 INHIBITORS
12/23/2004	WO2004111021A1 Cyclic hydroxylamine as psychoactive compounds
12/23/2004	WO2004111010A1 Isoquinoline -1,3,4-trione, the synthetic method and the use thereof
12/23/2004	WO2004111003A1 Amide derivatives as selective serotonin re-uptake inhibitors
12/23/2004	WO2004110995A1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors

1 ... 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 ... 1833